BETA


2013/0305(COD) New psychoactive substances

Progress: Awaiting Council 1st reading position / budgetary conciliation convocation

RoleCommitteeRapporteurShadows
Lead LIBE PROTASIEWICZ Jacek (icon: PPE PPE) HEDH Anna (icon: S&D S&D), WEBER Renate (icon: ALDE ALDE), SCHLYTER Carl (icon: Verts/ALE Verts/ALE), KIRKHOPE Timothy (icon: ECR ECR), TRIANTAPHYLLIDES Kyriacos (icon: GUE/NGL GUE/NGL)
Committee Opinion ENVI ANTONESCU Elena Oana (icon: PPE PPE)
Lead committee dossier:
Legal Basis:
TFEU 114

Events

2016/12/09
   CSL - Council Meeting
2015/10/09
   CSL - Council Meeting
2015/09/14
   CSL - Debate in Council
2015/02/05
   EP - Committee decision to open interinstitutional negotiations after 1st reading in Parliament
2014/09/26
   CSL - Council Meeting
2014/07/09
   Commission response to text adopted in plenary
Documents
2014/06/20
   CSL - Debate in Council
Documents
2014/06/20
   CSL - Council Meeting
2014/04/22
   FR_ASSEMBLY - Contribution
Documents
2014/04/17
   EP - Results of vote in Parliament
2014/04/17
   EP - Decision by Parliament, 1st reading/single reading
Details

The European Parliament adopted by 507 votes 37 with 33 abstentions, a legislative resolution on the proposal for a regulation of the European Parliament and of the Council on new psychoactive substances.

Parliament’s position in first reading following the ordinary legislative procedure amended the Commission position as follows:

Information exchange : to enable a more effective response to the rapid emergence and spread of new psychoactive substances across the Union, Parliament considered that the information exchange mechanism (the 'Early Warning System') should be maintained and further developed , in particular as regards to the collection and management of data on the detection and identification of new psychoactive substances.

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) should issue health alerts to all Member States, through the system for rapid exchange of information on new psychoactive substances if, on the basis of information received on a new psychoactive substances, this seemed to cause public health concerns. Those health alerts should also contain information regarding prevention, treatment and harm reduction measures that could be taken to address the risk of the substance. Information should include consumption and its patterns, serious intoxication or deaths, possible risks as well as the toxicity level, and data concerning manufacture.

Risk assessment : a risk assessment should be conducted if there were sufficient data available at Union level to suggest the need for a joint report of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and Europol.

Immediate risks to public health, and market restrictions: the proposal provided that the Commission should, by means of a Decision, prohibit the making available on the market to consumers of the new psychoactive substance if, based on existing information, it poses immediate risks to public health. The market restriction should not exceed a period of twelve months.

Members proposed that if the level of health, social and safety risks posed by the new psychoactive substance justified the introduction of permanent restriction measures, the duration of the temporary market restriction may be extended by a further 12 months , in the absence of permanent market restriction.

Low risks at Union level : the Commission should not adopt restriction measures on a new psychoactive substance if, based on the existing evidence and on prescribed criteria , it posed, overall, low health, social and safety risks at Union level.

However, where the decision to not adopt restriction measures on a new psychoactive substance that was considered to pose overall low health, social and safety risk at Union level was based on a partial or total lack of evidence, it should include an appropriate reference in the justification.

Parliament also stressed that Members States should not be prohibited from introducing or maintaining the more stringent measures regarding the specific risks the new psychoactive substance posed within their territory, independently of the classification of the substance by the Commission as posing low or moderate risks on the EU level.

A Member State willing to introduce a more stringent measure concerning the new psychoactive should immediately communicate the relevant draft laws, regulations or administrative provisions to the Commission and shall inform the other Member States.

Authorised use : decisions prohibiting the marketing of new psychoactive substance presenting a serious risk should not impede the free movement in the Union and the production, manufacture, making available on the market of new psychoactive substances for scientific research and development purposes , by duly authorised persons in establishments which were directly under the control of Member States' authorities or specifically approved by them.

For all of authorised uses, new psychoactive substances and products containing new psychoactive substances should include directions for use , including cautions, warnings and contraindications with other substances, to be either indicated on the label or included in the accompanying leaflet for the safety of the user.

Furthermore, Member States should take any appropriate measures to prevent the diversion to the illicit market of new psychoactive substances used for research and development purposes or for any other authorised uses.

Research, analysis, prevention and funding : the amended text provided that financial support and the necessary resources should be provided at Union and national level for the development, sharing and dissemination of information and knowledge on new psychoactive substances.

Moreover, the Commission and the Member States should promote the research into new psychoactive substances and ensure cooperation and coordination between networks at national and Union level in order to strengthen understanding of the phenomenon.

Prevention schemes as well as measures to raise awareness of the risks posed by psychoactive substances, such as educational information campaigns should be promoted.

Evaluation : the EMCDDA and Europol should report annually to the European Parliament, the Commission and Member States on the implementation of the Regulation. Five years after the entry into force of the Regulation and every five years thereafter, the Commission should:

· assess the implementation, application and effectiveness of this Regulation and publish a report. In this respect, the Commission, the EMCDDA and Europol should conduct post-risk assessments of new psychoactive substances;

· evaluate and if appropriate present a proposal for possible classification of groups of the new psychoactive substances in order to counteract the practise of bypassing the legislation in force by slight modifications of the chemical structure of the psychoactive substances.

The implementation reports should be published on a website and made publicly available.

Documents
2014/03/13
   EP - Committee report tabled for plenary, 1st reading/single reading
Details

The Committee on Civil Liberties, Justice and Home Affairs adopted the report by Jacek PROTASIEWICZ (EPP, PL) on the proposal for a regulation of the European Parliament and of the Council on new psychoactive substances.

The committee recommended that Parliament’s position in first reading following the ordinary legislative procedure should amend the Commission position as follows:

Information exchange : to enable a more effective response to the rapid emergence and spread of new psychoactive substances across the Union, Members considered that the information exchange mechanism (the 'Early Warning System') should be maintained and further developed, in particular as regards to the collection and management of data on the detection and identification of new psychoactive substances.

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) should issue health alerts to all Member States, through the system for rapid exchange of information on new psychoactive substances if, on the basis of information received on a new psychoactive substances, this seemed to cause public health concerns. Those health alerts should also contain information regarding prevention, treatment and harm reduction measures that could be taken to address the risk of the substance.

Immediate risks to public health, and market restrictions : the proposal provided that the Commission should, by means of a Decision, prohibit the making available on the market to consumers of the new psychoactive substance if, based on existing information, it poses immediate risks to public health. The market restriction should not exceed a period of twelve months.

Members proposed that if the level of health, social and safety risks posed by the new psychoactive substance justified the introduction of permanent restriction measures, the duration of the temporary market restriction may be extended by a further 12 months , in the absence of permanent market restriction.

Low risks at Union level : the Commission should not adopt restriction measures on a new psychoactive substance if, based on the existing evidence and on prescribed criteria , it posed, overall, low health, social and safety risks at Union level.

However, where the decision to not adopt restriction measures on a new psychoactive substance that was considered to pose overall low health, social and safety risk at Union level was based on a partial or total lack of evidence, it should include an appropriate reference in the justification.

The report also stressed that Members States should not be prohibited from introducing or maintaining the more stringent measures regarding the specific risks the new psychoactive substance posed within their territory, independently of the classification of the substance by the Commission as posing low or moderate risks on the EU level. The relevant laws, regulations or administrative provisions should be communicated to the Commission and the other Member States should be informed.

Authorised use : decisions prohibiting the marketing of new psychoactive substance presenting a serious risk should not impede the free movement in the Union and the production, manufacture, making available on the market of new psychoactive substances for scientific research and development purposes , by duly authorised persons in establishments which were directly under the control of Member States' authorities or specifically approved by them.

For all of authorised uses, new psychoactive substances and products containing new psychoactive substances should include directions for use , including cautions, warnings and contraindications with other substances, to be either indicated on the label or included in the accompanying leaflet for the safety of the user.

Furthermore, Member States should take any appropriate measures to prevent the diversion to the illicit market of new psychoactive substances used for research and development purposes or for any other authorised uses.

Research, analysis, prevention and funding : the amended text provided that financial support and the necessary resources should be provided at Union and national level for the development, sharing and dissemination of information and knowledge on new psychoactive substances.

Moreover, the Commission and the Member States should promote the research into new psychoactive substances and ensure cooperation and coordination between networks at national and Union level in order to strengthen understanding of the phenomenon.

Prevention schemes as well as measures to raise awareness of the risks posed by psychoactive substances, such as educational information campaigns should be promoted.

Evaluation: five years after the entry into force of the Regulation and every five years thereafter, the Commission should:

assess the implementation, application and effectiveness of this Regulation and publish a report. In this respect, the Commission, the EMCDDA and Europol should conduct post-risk assessments of new psychoactive substances; evaluate and if appropriate present a proposal for possible classification of groups of the new psychoactive substances in order to counteract the practise of bypassing the legislation in force by slight modifications of the chemical structure of the psychoactive substances.

Documents
2014/03/10
   EP - Vote in committee, 1st reading/single reading
2014/01/31
   EP - Committee opinion
Documents
2014/01/29
   EP - Amendments tabled in committee
Documents
2014/01/28
   CSL - Debate in Council
Documents
2014/01/28
   CSL - Council Meeting
2013/12/23
   EP - Committee draft report
Documents
2013/12/23
   NL_SENATE - Contribution
Documents
2013/11/25
   IT_SENATE - Contribution
Documents
2013/11/15
   ES_PARLIAMENT - Contribution
Documents
2013/11/07
   PT_PARLIAMENT - Contribution
Documents
2013/10/10
   EP - Committee Opinion
2013/10/08
   EP - Committee referral announced in Parliament, 1st reading/single reading
2013/10/07
   CSL - Council Meeting
2013/09/30
   EP - Responsible Committee
2013/09/17
   EC - Document attached to the procedure
2013/09/17
   EC - Document attached to the procedure
2013/09/17
   EC - Legislative proposal published
Details

PURPOSE: to approximate the rules relating to new psychoactive substances that are of concern at Union level whilst ensuring a high level of health, safety and consumer protection.

PROPOSED ACT: Regulation of the European Parliament and of the Council.

ROLE OF THE EUROPEAN PARLIAMENT: the European Parliament decides in accordance with the ordinary legislative procedure and on an equal footing with the Council.

BACKGROUND: new psychoactive substances, which may have numerous commercial and industrial uses, as well as scientific uses, can pose health, social and safety risks when consumed by humans. Consumption of new psychoactive substances appears to be increasing in Europe and use is predominant among young people . According to the 2011 Eurobarometer "Youth attitudes on drugs", 5% of young people in the EU have used such substances at least once in their life, with a peak of 16% in Ireland, and close to 10% in Poland, Latvia and the UK.

During the past years, Member States have notified an increasing number of new psychoactive substances to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). National restriction measures, which can vary depending on the Member State and on the substance, lead to obstacles to trade in licit uses, fragmentation, an uneven level playing field and legal uncertainties for economic operators, and make it difficult for companies to operate across the internal market. They make research more cumbersome, hampering the development of new uses for these substances.

In this context, the case for swifter, more effective and more proportionate action on new psychoactive substances at EU level is compelling, considering the rapid changes in this market, which put national authorities under pressure to act.

The Commission Communication " Towards a stronger European response to drugs ", adopted in October 2011, identified the spread of new psychoactive substances as one of the most challenging developments in drugs policy requiring a firmer EU response.

IMPACT ASSESSMENT: taking into account the results of impact assessment, the following solutions are preferred: (i) a more graduated and better targeted set of restriction measures on new psychoactive substances, which should not hinder the industrial use of substances; (ii) restriction measures should be introduced earlier; (iii) substances suspected to pose immediate public health risks should be subjected to temporary restrictions; (iv) restriction measures should be proportionate to a better determined level of risk of substances; (v) restriction measures should be introduced through a quicker procedure.

LEGAL BASIS: Article 114 of the Treaty on the Functioning of the European Union.

CONTENT: this proposed Regulation – which is intended to replace Council Decision 2005/387/JHA - aims at ensuring that trade in new psychoactive substances having industrial and commercial uses is not hindered and that the functioning of this market is improved, while the health and safety of individuals are protected from harmful substances, which cause concern at the EU level.

The proposal is accompanied by a proposal for a Directive amending Council Framework Decision 2004/757/JHA laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking.

The main elements of the proposal are as follows:

Exchange of information and temporary consumer market restrictions : this proposal sets up a robust system: (i) for exchanging rapidly information on new psychoactive substances emerging on the market, including on their commercial and industrial uses, for assessing the risks of substances that cause EU-wide concern and; (ii) for withdrawing from the market those substances that pose risks.

The substances suspected to pose immediate public health risk will be withdrawn from the consumer market temporarily, pending their risk assessment. Once the risk assessment is completed, measures will be taken proportionate to the risks of substances.

The proposal establishes the respective roles of Member States, the EMCDDA and Europol in the process of exchange of information on new psychoactive substances.

Low and moderate risks : according to the proposal, no restriction measures shall be introduced on new psychoactive substances posing low health, social and safety risks and provides a definition of low risks.

For substances posing moderate risks and permanent consumer market restrictions, they cannot be sold to consumers (except for uses specifically authorised, for instance by medicines legislation) but their trade is allowed for commercial and industrial purposes as well as for scientific research and development.

Severe risks : the proposal empowers the Commission to prohibit the production, manufacture, making available on the market, transport, importation or exportation of new psychoactive substances which pose severe health, social and safety risks, and provides a definition of severe risks.

New psychoactive substances posing severe risks will be subjected to permanent market restriction , covering both the consumer and commercial markets, and their use will only be possible for specifically authorised industrial and commercial purposes, as well as for scientific research and development. In addition, these substances will be subjected to EU criminal law provisions.

Sanctions : the proposal establishes the obligation for the Member States to lay down the rules on administrative sanctions applicable to infringements to market restriction, and to ensure that they are effective, proportionate and dissuasive.

BUDGETARY IMPLICATION: the proposal has no direct impact on the EU budget and does not create new tasks for the EMCDDA, Europol, the European Medicines Agencies, the European Chemicals Agency (ECHA) and the European Food Safety Authority (EFSA).

Documents

Votes

A7-0172/2014 - Jacek Protasiewicz - Résolution législative

2014/04/17 Outcome: +: 507, -: 37, 0: 33
DE FR PL ES IT RO GB BE AT BG SE CZ HU SK DK HR PT FI LT NL EL IE SI LV LU MT EE CY ??
Total
82
56
45
43
30
23
56
17
17
15
17
18
17
12
13
10
18
9
7
21
13
8
5
7
4
4
3
5
2
icon: PPE PPE
204

Czechia PPE

2

Denmark PPE

For (1)

1

Luxembourg PPE

2

Malta PPE

For (1)

1
2
2
icon: S&D S&D
144

Finland S&D

2

Netherlands S&D

2

Estonia S&D

For (1)

1
icon: ALDE ALDE
65

Slovakia ALDE

For (1)

1
3

Finland ALDE

1

Lithuania ALDE

1

Greece ALDE

1

Ireland ALDE

2

Slovenia ALDE

For (1)

1

Luxembourg ALDE

For (1)

1
2
icon: Verts/ALE Verts/ALE
45

United Kingdom Verts/ALE

4

Belgium Verts/ALE

2

Austria Verts/ALE

2

Denmark Verts/ALE

For (1)

1

Portugal Verts/ALE

For (1)

1

Finland Verts/ALE

2

Netherlands Verts/ALE

2

Latvia Verts/ALE

1

Luxembourg Verts/ALE

For (1)

1
icon: ECR ECR
42

Italy ECR

1

Denmark ECR

For (1)

1

Croatia ECR

For (1)

1

Latvia ECR

For (1)

1
icon: EFD EFD
22

United Kingdom EFD

3

Belgium EFD

For (1)

1

Slovakia EFD

For (1)

1

Denmark EFD

1

Finland EFD

For (1)

1

Lithuania EFD

2

Netherlands EFD

For (1)

1

Greece EFD

1
icon: NI NI
26

France NI

2

Spain NI

1

Italy NI

2

United Kingdom NI

Against (1)

Abstain (1)

4

Belgium NI

For (1)

1

Hungary NI

For (1)

3

Ireland NI

For (1)

1
icon: GUE/NGL GUE/NGL
29

Spain GUE/NGL

Against (1)

1

Sweden GUE/NGL

Against (1)

1

Czechia GUE/NGL

3

Denmark GUE/NGL

Against (1)

1
4

Netherlands GUE/NGL

2

Ireland GUE/NGL

Against (1)

1

Latvia GUE/NGL

Against (1)

1

Cyprus GUE/NGL

1
AmendmentsDossier
148 2013/0305(COD)
2014/01/10 ENVI 43 amendments...
source: PE-526.242
2014/01/29 LIBE 105 amendments...
source: PE-519.808

History

(these mark the time of scraping, not the official date of the change)

activities
  • date
    2013-09-17T00:00:00
    docs
    • url
      http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2013&nu_doc=619
      text
      • PURPOSE: to approximate the rules relating to new psychoactive substances that are of concern at Union level whilst ensuring a high level of health, safety and consumer protection.

        PROPOSED ACT: Regulation of the European Parliament and of the Council.

        ROLE OF THE EUROPEAN PARLIAMENT: the European Parliament decides in accordance with the ordinary legislative procedure and on an equal footing with the Council.

        BACKGROUND: new psychoactive substances, which may have numerous commercial and industrial uses, as well as scientific uses, can pose health, social and safety risks when consumed by humans. Consumption of new psychoactive substances appears to be increasing in Europe and use is predominant among young people. According to the 2011 Eurobarometer "Youth attitudes on drugs", 5% of young people in the EU have used such substances at least once in their life, with a peak of 16% in Ireland, and close to 10% in Poland, Latvia and the UK.

        During the past years, Member States have notified an increasing number of new psychoactive substances to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). National restriction measures, which can vary depending on the Member State and on the substance, lead to obstacles to trade in licit uses, fragmentation, an uneven level playing field and legal uncertainties for economic operators, and make it difficult for companies to operate across the internal market. They make research more cumbersome, hampering the development of new uses for these substances.

        In this context, the case for swifter, more effective and more proportionate action on new psychoactive substances at EU level is compelling, considering the rapid changes in this market, which put national authorities under pressure to act.

        The Commission Communication "Towards a stronger European response to drugs", adopted in October 2011, identified the spread of new psychoactive substances as one of the most challenging developments in drugs policy requiring a firmer EU response.

        IMPACT ASSESSMENT: taking into account the results of impact assessment, the following solutions are preferred: (i) a more graduated and better targeted set of restriction measures on new psychoactive substances, which should not hinder the industrial use of substances; (ii) restriction measures should be introduced earlier; (iii) substances suspected to pose immediate public health risks should be subjected to temporary restrictions; (iv) restriction measures should be proportionate to a better determined level of risk of substances; (v) restriction measures should be introduced through a quicker procedure.

        LEGAL BASIS: Article 114 of the Treaty on the Functioning of the European Union.

        CONTENT: this proposed Regulation – which is intended to replace Council Decision 2005/387/JHA - aims at ensuring that trade in new psychoactive substances having industrial and commercial uses is not hindered and that the functioning of this market is improved, while the health and safety of individuals are protected from harmful substances, which cause concern at the EU level.

        The proposal is accompanied by a proposal for a Directive amending Council Framework Decision 2004/757/JHA laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking.

        The main elements of the proposal are as follows:

        Exchange of information and temporary consumer market restrictions: this proposal sets up a robust system: (i) for exchanging rapidly information on new psychoactive substances emerging on the market, including on their commercial and industrial uses, for assessing the risks of substances that cause EU-wide concern and; (ii) for withdrawing from the market those substances that pose risks.

        The substances suspected to pose immediate public health risk will be withdrawn from the consumer market temporarily, pending their risk assessment. Once the risk assessment is completed, measures will be taken proportionate to the risks of substances.

        The proposal establishes the respective roles of Member States, the EMCDDA and Europol in the process of exchange of information on new psychoactive substances.

        Low and moderate risks: according to the proposal, no restriction measures shall be introduced on new psychoactive substances posing low health, social and safety risks and provides a definition of low risks.

        For substances posing moderate risks and permanent consumer market restrictions, they cannot be sold to consumers (except for uses specifically authorised, for instance by medicines legislation) but their trade is allowed for commercial and industrial purposes as well as for scientific research and development.

        Severe risks: the proposal empowers the Commission to prohibit the production, manufacture, making available on the market, transport, importation or exportation of new psychoactive substances which pose severe health, social and safety risks, and provides a definition of severe risks.

        New psychoactive substances posing severe risks will be subjected to permanent market restriction, covering both the consumer and commercial markets, and their use will only be possible for specifically authorised industrial and commercial purposes, as well as for scientific research and development. In addition, these substances will be subjected to EU criminal law provisions.

        Sanctions: the proposal establishes the obligation for the Member States to lay down the rules on administrative sanctions applicable to infringements to market restriction, and to ensure that they are effective, proportionate and dissuasive.

        BUDGETARY IMPLICATION: the proposal has no direct impact on the EU budget and does not create new tasks for the EMCDDA, Europol, the European Medicines Agencies, the European Chemicals Agency (ECHA) and the European Food Safety Authority (EFSA).

      title
      COM(2013)0619
      type
      Legislative proposal published
      celexid
      CELEX:52013PC0619:EN
    body
    EC
    commission
    • DG
      Commissioner
      REDING Viviane
    type
    Legislative proposal published
  • date
    2013-10-07T00:00:00
    body
    CSL
    type
    Council Meeting
    council
    Justice and Home Affairs (JHA)
    meeting_id
    3260
  • date
    2013-10-08T00:00:00
    body
    EP
    type
    Committee referral announced in Parliament, 1st reading/single reading
    committees
  • body
    CSL
    meeting_id
    3290
    docs
    • url
      http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=3290*&MEET_DATE=28/01/2014
      type
      Debate in Council
      title
      3290
    council
    Economic and Financial Affairs ECOFIN
    date
    2014-01-28T00:00:00
    type
    Council Meeting
  • date
    2014-03-10T00:00:00
    body
    EP
    type
    Vote in committee, 1st reading/single reading
    committees
  • body
    EP
    docs
    • url
      http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A7-2014-0172&language=EN
      text
      • The Committee on Civil Liberties, Justice and Home Affairs adopted the report by Jacek PROTASIEWICZ (EPP, PL) on the proposal for a regulation of the European Parliament and of the Council on new psychoactive substances.

        The committee recommended that Parliament’s position in first reading following the ordinary legislative procedure should amend the Commission position as follows:

        Information exchange: to enable a more effective response to the rapid emergence and spread of new psychoactive substances across the Union, Members considered that the information exchange mechanism (the 'Early Warning System') should be maintained and further developed, in particular as regards to the collection and management of data on the detection and identification of new psychoactive substances.

        The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) should issue health alerts to all Member States, through the system for rapid exchange of information on new psychoactive substances if, on the basis of information received on a new psychoactive substances, this seemed to cause public health concerns. Those health alerts should also contain information regarding prevention, treatment and harm reduction measures that could be taken to address the risk of the substance.

        Immediate risks to public health, and market restrictions: the proposal provided that the Commission should, by means of a Decision, prohibit the making available on the market to consumers of the new psychoactive substance if, based on existing information, it poses immediate risks to public health. The market restriction should not exceed a period of twelve months.

        Members proposed that if the level of health, social and safety risks posed by the new psychoactive substance justified the introduction of permanent restriction measures, the duration of the temporary market restriction may be extended by a further 12 months, in the absence of permanent market restriction.

        Low risks at Union level: the Commission should not adopt restriction measures on a new psychoactive substance if, based on the existing evidence and on prescribed criteria, it posed, overall, low health, social and safety risks at Union level.

        However, where the decision to not adopt restriction measures on a new psychoactive substance that was considered to pose overall low health, social and safety risk at Union level was based on a partial or total lack of evidence, it should include an appropriate reference in the justification.

        The report also stressed that Members States should not be prohibited from introducing or maintaining the more stringent measures regarding the specific risks the new psychoactive substance posed within their territory, independently of the classification of the substance by the Commission as posing low or moderate risks on the EU level. The relevant laws, regulations or administrative provisions should be communicated to the Commission and the other Member States should be informed.

        Authorised use: decisions prohibiting the marketing of new psychoactive substance presenting a serious risk should not impede the free movement in the Union and the production, manufacture, making available on the market of new psychoactive substances for scientific research and development purposes, by duly authorised persons in establishments which were directly under the control of Member States' authorities or specifically approved by them.

        For all of authorised uses, new psychoactive substances and products containing new psychoactive substances should include directions for use, including cautions, warnings and contraindications with other substances, to be either indicated on the label or included in the accompanying leaflet for the safety of the user.

        Furthermore, Member States should take any appropriate measures to prevent the diversion to the illicit market of new psychoactive substances used for research and development purposes or for any other authorised uses.

        Research, analysis, prevention and funding: the amended text provided that financial support and the necessary resources should be provided at Union and national level for the development, sharing and dissemination of information and knowledge on new psychoactive substances. 

        Moreover, the Commission and the Member States should promote the research into new psychoactive substances and ensure cooperation and coordination between networks at national and Union level in order to strengthen understanding of the phenomenon. 

        Prevention schemes as well as measures to raise awareness of the risks posed by psychoactive substances, such as educational information campaigns should be promoted.

        Evaluation: five years after the entry into force of the Regulation and every five years thereafter, the Commission should:

        • assess the implementation, application and effectiveness of this Regulation and publish a report. In this respect, the Commission, the EMCDDA and Europol should conduct post-risk assessments of new psychoactive substances;
        • evaluate and if appropriate present a proposal for possible classification of groups of the new psychoactive substances in order to counteract the practise of bypassing the legislation in force by slight modifications of the chemical structure of the psychoactive substances.
      type
      Committee report tabled for plenary, 1st reading/single reading
      title
      A7-0172/2014
    type
    Committee report tabled for plenary, 1st reading/single reading
    committees
    date
    2014-03-13T00:00:00
  • date
    2014-04-17T00:00:00
    docs
    body
    EP
    type
    Results of vote in Parliament
  • body
    CSL
    meeting_id
    3324
    docs
    • url
      http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=3324*&MEET_DATE=20/06/2014
      type
      Debate in Council
      title
      3324
    council
    Economic and Financial Affairs ECOFIN
    date
    2014-06-20T00:00:00
    type
    Council Meeting
  • date
    2014-09-26T00:00:00
    body
    CSL
    type
    Council Meeting
    council
    Competitiveness (Internal Market, Industry, Research and Space)
    meeting_id
    3333
  • date
    2015-02-05T00:00:00
    body
    unknown
    type
    Committee decision to open interinstitutional negotiations after 1st reading in Parliament
  • date
    2015-09-14T00:00:00
    body
    CSL
    type
    Debate in Council
  • date
    2015-10-09T00:00:00
    body
    CSL
    type
    Council Meeting
    council
    Justice and Home Affairs (JHA)
    meeting_id
    3415
  • date
    2016-12-09T00:00:00
    body
    CSL
    type
    Council Meeting
    council
    Justice and Home Affairs (JHA)
    meeting_id
    3508
commission
  • body
    EC
    dg
    Justice and Consumers
    commissioner
    REDING Viviane
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Civil Liberties, Justice and Home Affairs
committee
LIBE
date
  • 2013-09-30T00:00:00
rapporteur
  • name
    PROTASIEWICZ Jacek
    group
    European People's Party (Christian Democrats)
    abbr
    PPE
shadows
committees/0
body
EP
responsible
False
committee
ENVI
date
2013-10-10T00:00:00
committee_full
Environment, Public Health and Food Safety
rapporteur
  • group
    PPE
    name
    ANTONESCU Elena Oana
committees/1
type
Committee Opinion
body
EP
associated
False
committee_full
Environment, Public Health and Food Safety
committee
ENVI
date
  • 2013-10-10T00:00:00
rapporteur
  • name
    ANTONESCU Elena Oana
    group
    European People's Party (Christian Democrats)
    abbr
    PPE
committees/1
body
EP
shadows
responsible
True
committee
LIBE
date
2013-09-30T00:00:00
committee_full
Civil Liberties, Justice and Home Affairs
rapporteur
  • group
    PPE
    name
    PROTASIEWICZ Jacek
council
  • body
    CSL
    type
    Council Meeting
    council
    Justice and Home Affairs (JHA)
    meeting_id
    3508
    url
    http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=3508*&MEET_DATE=09/12/2016
    date
    2016-12-09T00:00:00
  • body
    CSL
    type
    Council Meeting
    council
    Justice and Home Affairs (JHA)
    meeting_id
    3415
    url
    http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=3415*&MEET_DATE=09/10/2015
    date
    2015-10-09T00:00:00
  • body
    CSL
    type
    Council Meeting
    council
    Competitiveness (Internal Market, Industry, Research and Space)
    meeting_id
    3333
    url
    http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=3333*&MEET_DATE=26/09/2014
    date
    2014-09-26T00:00:00
  • body
    CSL
    type
    Council Meeting
    council
    Economic and Financial Affairs ECOFIN
    meeting_id
    3324
    url
    http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=3324*&MEET_DATE=20/06/2014
    date
    2014-06-20T00:00:00
  • body
    CSL
    type
    Council Meeting
    council
    Economic and Financial Affairs ECOFIN
    meeting_id
    3290
    url
    http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=3290*&MEET_DATE=28/01/2014
    date
    2014-01-28T00:00:00
  • body
    CSL
    type
    Council Meeting
    council
    Justice and Home Affairs (JHA)
    meeting_id
    3260
    url
    http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=3260*&MEET_DATE=07/10/2013
    date
    2013-10-07T00:00:00
docs
  • date
    2013-09-17T00:00:00
    docs
    type
    Document attached to the procedure
    body
    EC
  • date
    2013-09-17T00:00:00
    docs
    type
    Document attached to the procedure
    body
    EC
  • date
    2013-12-23T00:00:00
    docs
    • url
      http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE519.611
      title
      PE519.611
    type
    Committee draft report
    body
    EP
  • date
    2014-01-29T00:00:00
    docs
    • url
      http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE519.808
      title
      PE519.808
    type
    Amendments tabled in committee
    body
    EP
  • date
    2014-01-31T00:00:00
    docs
    • url
      http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE524.592&secondRef=02
      title
      PE524.592
    committee
    ENVI
    type
    Committee opinion
    body
    EP
  • date
    2014-07-09T00:00:00
    docs
    • url
      /oeil/spdoc.do?i=24373&j=0&l=en
      title
      SP(2014)471
    type
    Commission response to text adopted in plenary
  • date
    2014-04-22T00:00:00
    docs
    • url
      http://www.connefof.europarl.europa.eu/connefof/app/exp/COM(2013)0619
      title
      COM(2013)0619
    type
    Contribution
    body
    FR_ASSEMBLY
  • date
    2013-11-07T00:00:00
    docs
    • url
      http://www.connefof.europarl.europa.eu/connefof/app/exp/COM(2013)0619
      title
      COM(2013)0619
    type
    Contribution
    body
    PT_PARLIAMENT
  • date
    2013-11-15T00:00:00
    docs
    • url
      http://www.connefof.europarl.europa.eu/connefof/app/exp/COM(2013)0619
      title
      COM(2013)0619
    type
    Contribution
    body
    ES_PARLIAMENT
  • date
    2013-11-25T00:00:00
    docs
    • url
      http://www.connefof.europarl.europa.eu/connefof/app/exp/COM(2013)0619
      title
      COM(2013)0619
    type
    Contribution
    body
    IT_SENATE
  • date
    2013-12-23T00:00:00
    docs
    • url
      http://www.connefof.europarl.europa.eu/connefof/app/exp/COM(2013)0619
      title
      COM(2013)0619
    type
    Contribution
    body
    NL_SENATE
events
  • date
    2013-09-17T00:00:00
    type
    Legislative proposal published
    body
    EC
    docs
    summary
  • date
    2013-10-08T00:00:00
    type
    Committee referral announced in Parliament, 1st reading/single reading
    body
    EP
  • date
    2014-01-28T00:00:00
    type
    Debate in Council
    body
    CSL
    docs
    • url
      http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=3290*&MEET_DATE=28/01/2014
      title
      3290
  • date
    2014-03-10T00:00:00
    type
    Vote in committee, 1st reading/single reading
    body
    EP
  • date
    2014-03-13T00:00:00
    type
    Committee report tabled for plenary, 1st reading/single reading
    body
    EP
    docs
    • url
      http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A7-2014-0172&language=EN
      title
      A7-0172/2014
    summary
  • date
    2014-04-17T00:00:00
    type
    Results of vote in Parliament
    body
    EP
    docs
    • url
      https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=24373&l=en
      title
      Results of vote in Parliament
  • date
    2014-04-17T00:00:00
    type
    Decision by Parliament, 1st reading/single reading
    body
    EP
    docs
    • url
      http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P7-TA-2014-0453
      title
      T7-0453/2014
    summary
  • date
    2014-06-20T00:00:00
    type
    Debate in Council
    body
    CSL
    docs
    • url
      http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=3324*&MEET_DATE=20/06/2014
      title
      3324
  • date
    2015-02-05T00:00:00
    type
    Committee decision to open interinstitutional negotiations after 1st reading in Parliament
    body
    EP
  • date
    2015-09-14T00:00:00
    type
    Debate in Council
    body
    CSL
other
  • body
    CSL
    type
    Council Meeting
    council
    Former Council configuration
  • body
    EC
    dg
    commissioner
    REDING Viviane
otherinst
  • name
    European Economic and Social Committee
procedure/Mandatory consultation of other institutions
European Economic and Social Committee
procedure/Modified legal basis
Old
Rules of Procedure of the European Parliament EP 150
New
Rules of Procedure EP 150
procedure/dossier_of_the_committee
Old
LIBE/7/13824
New
  • LIBE/7/13824
procedure/instrument
Old
Regulation
New
  • Regulation
  • See also 2013/0304(COD)
procedure/other_consulted_institutions
European Economic and Social Committee
procedure/subject
Old
  • 4.20.03 Drug addiction, alcoholism, smoking
  • 7.30.30.04 Action to combat drugs and drug-trafficking
New
4.20.03
Drug addiction, alcoholism, smoking
7.30.30.04
Action to combat drugs and drug-trafficking
procedure/summary
  • See also
activities/0/commission/0/DG
Old
Justice
New
url
http://ec.europa.eu/info/departments/justice-and-consumers_en
title
Justice and Consumers
other/1/dg
Old
Justice
New
url
http://ec.europa.eu/info/departments/justice-and-consumers_en
title
Justice and Consumers
procedure/Mandatory consultation of other institutions
Old
Economic and Social Committee
New
European Economic and Social Committee
activities/0/commission/0/DG
Old
url
http://ec.europa.eu/justice/
title
Justice
New
Justice
other/1/dg
Old
url
http://ec.europa.eu/justice/
title
Justice
New
Justice
activities/12
date
2016-12-09T00:00:00
body
CSL
type
Council Meeting
council
Justice and Home Affairs (JHA)
meeting_id
3508
activities/9/type
Old
Opening of interinstitutional negotiations after 1st reading in Parliament
New
Committee decision to open interinstitutional negotiations after 1st reading in Parliament
activities/0/docs/0/celexid
CELEX:52013PC0619:EN
activities/9
date
2015-02-05T00:00:00
body
unknown
type
Opening of interinstitutional negotiations after 1st reading in Parliament
activities/10
date
2015-09-14T00:00:00
body
CSL
type
Debate in Council
activities/11
date
2015-10-09T00:00:00
body
CSL
type
Council Meeting
council
Justice and Home Affairs (JHA)
meeting_id
3415
activities/0/docs/0/celexid
CELEX:52013PC0619:EN
activities/0/docs/0/celexid
CELEX:52013PC0619:EN
activities/0/docs/0/celexid
CELEX:52013PC0619:EN
links/European Commission/title
Old
PreLex
New
EUR-Lex
activities/8
date
2014-09-26T00:00:00
body
CSL
type
Council Meeting
council
Competitiveness (Internal Market, Industry, Research and Space)
meeting_id
3333
activities/2/committees/0/rapporteur/0/mepref
Old
4de182e70fb8127435bdbb4f
New
4f1ac5f2b819f25efd00000f
activities/2/committees/1/rapporteur/0/mepref
Old
4de187870fb8127435bdc1f0
New
4f1ada95b819f207b300007c
activities/2/committees/1/shadows/0/mepref
Old
4de185620fb8127435bdbee9
New
4f1ac900b819f25efd000105
activities/2/committees/1/shadows/1/mepref
Old
4de189630fb8127435bdc48f
New
4f1adc87b819f207b3000121
activities/2/committees/1/shadows/2/mepref
Old
4de1887b0fb8127435bdc353
New
4f1adb22b819f207b30000ab
activities/2/committees/1/shadows/3/mepref
Old
4de185d80fb8127435bdbf86
New
4f1ac998b819f25efd000144
activities/2/committees/1/shadows/4/mepref
Old
4de188e10fb8127435bdc3e4
New
4f1adc10b819f207b30000fc
activities/4/committees/0/rapporteur/0/mepref
Old
4de182e70fb8127435bdbb4f
New
4f1ac5f2b819f25efd00000f
activities/4/committees/1/rapporteur/0/mepref
Old
4de187870fb8127435bdc1f0
New
4f1ada95b819f207b300007c
activities/4/committees/1/shadows/0/mepref
Old
4de185620fb8127435bdbee9
New
4f1ac900b819f25efd000105
activities/4/committees/1/shadows/1/mepref
Old
4de189630fb8127435bdc48f
New
4f1adc87b819f207b3000121
activities/4/committees/1/shadows/2/mepref
Old
4de1887b0fb8127435bdc353
New
4f1adb22b819f207b30000ab
activities/4/committees/1/shadows/3/mepref
Old
4de185d80fb8127435bdbf86
New
4f1ac998b819f25efd000144
activities/4/committees/1/shadows/4/mepref
Old
4de188e10fb8127435bdc3e4
New
4f1adc10b819f207b30000fc
activities/5/committees/0/rapporteur/0/mepref
Old
4de182e70fb8127435bdbb4f
New
4f1ac5f2b819f25efd00000f
activities/5/committees/1/rapporteur/0/mepref
Old
4de187870fb8127435bdc1f0
New
4f1ada95b819f207b300007c
activities/5/committees/1/shadows/0/mepref
Old
4de185620fb8127435bdbee9
New
4f1ac900b819f25efd000105
activities/5/committees/1/shadows/1/mepref
Old
4de189630fb8127435bdc48f
New
4f1adc87b819f207b3000121
activities/5/committees/1/shadows/2/mepref
Old
4de1887b0fb8127435bdc353
New
4f1adb22b819f207b30000ab
activities/5/committees/1/shadows/3/mepref
Old
4de185d80fb8127435bdbf86
New
4f1ac998b819f25efd000144
activities/5/committees/1/shadows/4/mepref
Old
4de188e10fb8127435bdc3e4
New
4f1adc10b819f207b30000fc
committees/0/rapporteur/0/mepref
Old
4de182e70fb8127435bdbb4f
New
4f1ac5f2b819f25efd00000f
committees/1/rapporteur/0/mepref
Old
4de187870fb8127435bdc1f0
New
4f1ada95b819f207b300007c
committees/1/shadows/0/mepref
Old
4de185620fb8127435bdbee9
New
4f1ac900b819f25efd000105
committees/1/shadows/1/mepref
Old
4de189630fb8127435bdc48f
New
4f1adc87b819f207b3000121
committees/1/shadows/2/mepref
Old
4de1887b0fb8127435bdc353
New
4f1adb22b819f207b30000ab
committees/1/shadows/3/mepref
Old
4de185d80fb8127435bdbf86
New
4f1ac998b819f25efd000144
committees/1/shadows/4/mepref
Old
4de188e10fb8127435bdc3e4
New
4f1adc10b819f207b30000fc
activities/6/docs/0
url
http://www.europarl.europa.eu/oeil/popups/sda.do?id=24373&l=en
type
Results of vote in Parliament
title
Results of vote in Parliament
activities/6/type
Old
Decision by Parliament, 1st reading/single reading
New
Results of vote in Parliament
activities/2/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/2/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/2/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/2/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/2/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/4/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/4/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/4/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/4/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/4/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/5/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/5/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/5/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/5/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/5/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
committees/1/shadows/0/group
Old
S&D
New
S&D
committees/1/shadows/1/group
Old
ALDE
New
ALDE
committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
committees/1/shadows/3/group
Old
ECR
New
ECR
committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/2/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/2/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/2/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/2/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/2/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/4/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/4/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/4/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/4/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/4/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/5/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/5/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/5/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/5/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/5/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
committees/1/shadows/0/group
Old
S&D
New
S&D
committees/1/shadows/1/group
Old
ALDE
New
ALDE
committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
committees/1/shadows/3/group
Old
ECR
New
ECR
committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/2/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/2/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/2/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/2/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/2/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/4/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/4/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/4/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/4/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/4/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/5/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/5/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/5/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/5/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/5/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
committees/1/shadows/0/group
Old
S&D
New
S&D
committees/1/shadows/1/group
Old
ALDE
New
ALDE
committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
committees/1/shadows/3/group
Old
ECR
New
ECR
committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/2/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/2/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/2/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/2/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/2/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/4/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/4/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/4/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/4/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/4/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/5/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/5/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/5/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/5/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/5/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
committees/1/shadows/0/group
Old
S&D
New
S&D
committees/1/shadows/1/group
Old
ALDE
New
ALDE
committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
committees/1/shadows/3/group
Old
ECR
New
ECR
committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/2/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/2/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/2/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/2/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/2/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/4/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/4/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/4/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/4/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/4/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/5/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/5/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/5/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/5/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/5/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
committees/1/shadows/0/group
Old
S&D
New
S&D
committees/1/shadows/1/group
Old
ALDE
New
ALDE
committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
committees/1/shadows/3/group
Old
ECR
New
ECR
committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/2/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/2/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/2/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/2/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/2/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/4/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/4/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/4/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/4/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/4/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/5/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/5/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/5/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/5/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/5/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
committees/1/shadows/0/group
Old
S&D
New
S&D
committees/1/shadows/1/group
Old
ALDE
New
ALDE
committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
committees/1/shadows/3/group
Old
ECR
New
ECR
committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/2/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/2/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/2/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/2/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/2/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/4/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/4/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/4/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/4/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/4/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/5/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/5/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/5/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/5/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/5/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
committees/1/shadows/0/group
Old
S&D
New
S&D
committees/1/shadows/1/group
Old
ALDE
New
ALDE
committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
committees/1/shadows/3/group
Old
ECR
New
ECR
committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/2/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/2/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/2/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/2/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/2/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/4/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/4/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/4/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/4/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/4/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/5/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/5/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/5/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/5/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/5/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
committees/1/shadows/0/group
Old
S&D
New
S&D
committees/1/shadows/1/group
Old
ALDE
New
ALDE
committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
committees/1/shadows/3/group
Old
ECR
New
ECR
committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/2/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/2/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/2/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/2/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/2/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/4/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/4/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/4/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/4/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/4/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/5/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/5/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/5/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/5/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/5/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
committees/1/shadows/0/group
Old
S&D
New
S&D
committees/1/shadows/1/group
Old
ALDE
New
ALDE
committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
committees/1/shadows/3/group
Old
ECR
New
ECR
committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/2/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/2/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/2/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/2/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/2/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/4/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/4/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/4/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/4/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/4/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/5/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/5/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/5/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/5/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/5/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
committees/1/shadows/0/group
Old
S&D
New
S&D
committees/1/shadows/1/group
Old
ALDE
New
ALDE
committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
committees/1/shadows/3/group
Old
ECR
New
ECR
committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/2/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/2/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/2/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/2/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/2/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/4/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/4/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/4/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/4/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/4/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/5/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/5/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/5/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/5/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/5/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
committees/1/shadows/0/group
Old
S&D
New
S&D
committees/1/shadows/1/group
Old
ALDE
New
ALDE
committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
committees/1/shadows/3/group
Old
ECR
New
ECR
committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/2/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/2/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/2/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/2/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/2/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/4/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/4/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/4/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/4/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/4/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/5/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/5/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/5/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/5/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/5/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
committees/1/shadows/0/group
Old
S&D
New
S&D
committees/1/shadows/1/group
Old
ALDE
New
ALDE
committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
committees/1/shadows/3/group
Old
ECR
New
ECR
committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/2/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/2/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/2/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/2/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/2/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/4/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/4/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/4/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/4/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/4/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/5/committees/1/shadows/0/group
Old
S&D
New
S&D
activities/5/committees/1/shadows/1/group
Old
ALDE
New
ALDE
activities/5/committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
activities/5/committees/1/shadows/3/group
Old
ECR
New
ECR
activities/5/committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
committees/1/shadows/0/group
Old
S&D
New
S&D
committees/1/shadows/1/group
Old
ALDE
New
ALDE
committees/1/shadows/2/group
Old
Verts/ALE
New
Verts/ALE
committees/1/shadows/3/group
Old
ECR
New
ECR
committees/1/shadows/4/group
Old
GUE/NGL
New
GUE/NGL
activities/2/committees/0/date
2013-10-10T00:00:00
activities/2/committees/0/rapporteur
  • group
    PPE
    name
    ANTONESCU Elena Oana
activities/2/committees/1/date
2013-09-30T00:00:00
activities/2/committees/1/rapporteur
  • group
    PPE
    name
    PROTASIEWICZ Jacek
activities/2/committees/1/shadows
  • group
    S&D
    name
    HEDH Anna
  • group
    ALDE
    name
    WEBER Renate
  • group
    Verts/ALE
    name
    SCHLYTER Carl
  • group
    ECR
    name
    KIRKHOPE Timothy
  • group
    GUE/NGL
    name
    TRIANTAPHYLLIDES Kyriacos
activities/4/committees/0/date
2013-10-10T00:00:00
activities/4/committees/0/rapporteur
  • group
    PPE
    name
    ANTONESCU Elena Oana
activities/4/committees/1/date
2013-09-30T00:00:00
activities/4/committees/1/rapporteur
  • group
    PPE
    name
    PROTASIEWICZ Jacek
activities/4/committees/1/shadows
  • group
    S&D
    name
    HEDH Anna
  • group
    ALDE
    name
    WEBER Renate
  • group
    Verts/ALE
    name
    SCHLYTER Carl
  • group
    ECR
    name
    KIRKHOPE Timothy
  • group
    GUE/NGL
    name
    TRIANTAPHYLLIDES Kyriacos
activities/5/committees/0/date
2013-10-10T00:00:00
activities/5/committees/0/rapporteur
  • group
    PPE
    name
    ANTONESCU Elena Oana
activities/5/committees/1/date
2013-09-30T00:00:00
activities/5/committees/1/rapporteur
  • group
    PPE
    name
    PROTASIEWICZ Jacek
activities/5/committees/1/shadows
  • group
    S&D
    name
    HEDH Anna
  • group
    ALDE
    name
    WEBER Renate
  • group
    Verts/ALE
    name
    SCHLYTER Carl
  • group
    ECR
    name
    KIRKHOPE Timothy
  • group
    GUE/NGL
    name
    TRIANTAPHYLLIDES Kyriacos
committees/0/date
2013-10-10T00:00:00
committees/0/rapporteur
  • group
    PPE
    name
    ANTONESCU Elena Oana
committees/1/date
2013-09-30T00:00:00
committees/1/rapporteur
  • group
    PPE
    name
    PROTASIEWICZ Jacek
committees/1/shadows
  • group
    S&D
    name
    HEDH Anna
  • group
    ALDE
    name
    WEBER Renate
  • group
    Verts/ALE
    name
    SCHLYTER Carl
  • group
    ECR
    name
    KIRKHOPE Timothy
  • group
    GUE/NGL
    name
    TRIANTAPHYLLIDES Kyriacos
activities/2/committees/0/date
2013-10-10T00:00:00
activities/2/committees/0/rapporteur
  • group
    EPP
    name
    ANTONESCU Elena Oana
activities/2/committees/1/date
2013-09-30T00:00:00
activities/2/committees/1/rapporteur
  • group
    EPP
    name
    PROTASIEWICZ Jacek
activities/2/committees/1/shadows
  • group
    S&D
    name
    HEDH Anna
  • group
    ALDE
    name
    WEBER Renate
  • group
    Verts/ALE
    name
    SCHLYTER Carl
  • group
    ECR
    name
    KIRKHOPE Timothy
  • group
    GUE/NGL
    name
    TRIANTAPHYLLIDES Kyriacos
activities/4/committees/0/date
2013-10-10T00:00:00
activities/4/committees/0/rapporteur
  • group
    EPP
    name
    ANTONESCU Elena Oana
activities/4/committees/1/date
2013-09-30T00:00:00
activities/4/committees/1/rapporteur
  • group
    EPP
    name
    PROTASIEWICZ Jacek
activities/4/committees/1/shadows
  • group
    S&D
    name
    HEDH Anna
  • group
    ALDE
    name
    WEBER Renate
  • group
    Verts/ALE
    name
    SCHLYTER Carl
  • group
    ECR
    name
    KIRKHOPE Timothy
  • group
    GUE/NGL
    name
    TRIANTAPHYLLIDES Kyriacos
activities/5/committees/0/date
2013-10-10T00:00:00
activities/5/committees/0/rapporteur
  • group
    EPP
    name
    ANTONESCU Elena Oana
activities/5/committees/1/date
2013-09-30T00:00:00
activities/5/committees/1/rapporteur
  • group
    EPP
    name
    PROTASIEWICZ Jacek
activities/5/committees/1/shadows
  • group
    S&D
    name
    HEDH Anna
  • group
    ALDE
    name
    WEBER Renate
  • group
    Verts/ALE
    name
    SCHLYTER Carl
  • group
    ECR
    name
    KIRKHOPE Timothy
  • group
    GUE/NGL
    name
    TRIANTAPHYLLIDES Kyriacos
activities/7
body
CSL
meeting_id
3324
docs
  • url
    http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=3324*&MEET_DATE=20/06/2014
    type
    Debate in Council
    title
    3324
council
Economic and Financial Affairs ECOFIN
date
2014-06-20T00:00:00
type
Council Meeting
committees/0/date
2013-10-10T00:00:00
committees/0/rapporteur
  • group
    EPP
    name
    ANTONESCU Elena Oana
committees/1/date
2013-09-30T00:00:00
committees/1/rapporteur
  • group
    EPP
    name
    PROTASIEWICZ Jacek
committees/1/shadows
  • group
    S&D
    name
    HEDH Anna
  • group
    ALDE
    name
    WEBER Renate
  • group
    Verts/ALE
    name
    SCHLYTER Carl
  • group
    ECR
    name
    KIRKHOPE Timothy
  • group
    GUE/NGL
    name
    TRIANTAPHYLLIDES Kyriacos
procedure/Modified legal basis
Rules of Procedure of the European Parliament EP 150
activities/6/docs/0/text
  • The European Parliament adopted by 507 votes 37 with 33 abstentions, a legislative resolution on the proposal for a regulation of the European Parliament and of the Council on new psychoactive substances.

    Parliament’s position in first reading following the ordinary legislative procedure amended the Commission position as follows:

    Information exchange: to enable a more effective response to the rapid emergence and spread of new psychoactive substances across the Union, Parliament considered that the information exchange mechanism (the 'Early Warning System') should be maintained and further developed, in particular as regards to the collection and management of data on the detection and identification of new psychoactive substances.

    The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) should issue health alerts to all Member States, through the system for rapid exchange of information on new psychoactive substances if, on the basis of information received on a new psychoactive substances, this seemed to cause public health concerns. Those health alerts should also contain information regarding prevention, treatment and harm reduction measures that could be taken to address the risk of the substance. Information should include consumption and its patterns, serious intoxication or deaths, possible risks as well as the toxicity level, and data concerning manufacture.

    Risk assessment: a risk assessment should be conducted if there were sufficient data available at Union level to suggest the need for a joint report of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and Europol.

    Immediate risks to public health, and market restrictions: the proposal provided that the Commission should, by means of a Decision, prohibit the making available on the market to consumers of the new psychoactive substance if, based on existing information, it poses immediate risks to public health. The market restriction should not exceed a period of twelve months.

    Members proposed that if the level of health, social and safety risks posed by the new psychoactive substance justified the introduction of permanent restriction measures, the duration of the temporary market restriction may be extended by a further 12 months, in the absence of permanent market restriction.

    Low risks at Union level: the Commission should not adopt restriction measures on a new psychoactive substance if, based on the existing evidence and on prescribed criteria, it posed, overall, low health, social and safety risks at Union level.

    However, where the decision to not adopt restriction measures on a new psychoactive substance that was considered to pose overall low health, social and safety risk at Union level was based on a partial or total lack of evidence, it should include an appropriate reference in the justification.

    Parliament also stressed that Members States should not be prohibited from introducing or maintaining the more stringent measures regarding the specific risks the new psychoactive substance posed within their territory, independently of the classification of the substance by the Commission as posing low or moderate risks on the EU level.

    A Member State willing to introduce a more stringent measure concerning the new psychoactive should immediately communicate the relevant draft laws, regulations or administrative provisions to the Commission and shall inform the other Member States.

    Authorised use: decisions prohibiting the marketing of new psychoactive substance presenting a serious risk should not impede the free movement in the Union and the production, manufacture, making available on the market of new psychoactive substances for scientific research and development purposes, by duly authorised persons in establishments which were directly under the control of Member States' authorities or specifically approved by them.

    For all of authorised uses, new psychoactive substances and products containing new psychoactive substances should include directions for use, including cautions, warnings and contraindications with other substances, to be either indicated on the label or included in the accompanying leaflet for the safety of the user.

    Furthermore, Member States should take any appropriate measures to prevent the diversion to the illicit market of new psychoactive substances used for research and development purposes or for any other authorised uses.

    Research, analysis, prevention and funding: the amended text provided that financial support and the necessary resources should be provided at Union and national level for the development, sharing and dissemination of information and knowledge on new psychoactive substances. 

    Moreover, the Commission and the Member States should promote the research into new psychoactive substances and ensure cooperation and coordination between networks at national and Union level in order to strengthen understanding of the phenomenon. 

    Prevention schemes as well as measures to raise awareness of the risks posed by psychoactive substances, such as educational information campaigns should be promoted.

    Evaluation: the EMCDDA and Europol should report annually to the European Parliament, the Commission and Member States on the implementation of the Regulation. Five years after the entry into force of the Regulation and every five years thereafter, the Commission should:

    ·        assess the implementation, application and effectiveness of this Regulation and publish a report. In this respect, the Commission, the EMCDDA and Europol should conduct post-risk assessments of new psychoactive substances;

    ·        evaluate and if appropriate present a proposal for possible classification of groups of the new psychoactive substances in order to counteract the practise of bypassing the legislation in force by slight modifications of the chemical structure of the psychoactive substances.

    The implementation reports should be published on a website and made publicly available.

activities/6/docs/0/url
http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P7-TA-2014-0453
activities/6
date
2014-04-17T00:00:00
docs
  • type
    Decision by Parliament, 1st reading/single reading
    title
    T7-0453/2014
body
EP
type
Decision by Parliament, 1st reading/single reading
procedure/stage_reached
Old
Awaiting Parliament 1st reading / single reading / budget 1st stage
New
Awaiting Council 1st reading position / budgetary conciliation convocation
activities/0
date
2013-09-17T00:00:00
docs
  • url
    http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2013&nu_doc=619
    text
    • PURPOSE: to approximate the rules relating to new psychoactive substances that are of concern at Union level whilst ensuring a high level of health, safety and consumer protection.

      PROPOSED ACT: Regulation of the European Parliament and of the Council.

      ROLE OF THE EUROPEAN PARLIAMENT: the European Parliament decides in accordance with the ordinary legislative procedure and on an equal footing with the Council.

      BACKGROUND: new psychoactive substances, which may have numerous commercial and industrial uses, as well as scientific uses, can pose health, social and safety risks when consumed by humans. Consumption of new psychoactive substances appears to be increasing in Europe and use is predominant among young people. According to the 2011 Eurobarometer "Youth attitudes on drugs", 5% of young people in the EU have used such substances at least once in their life, with a peak of 16% in Ireland, and close to 10% in Poland, Latvia and the UK.

      During the past years, Member States have notified an increasing number of new psychoactive substances to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). National restriction measures, which can vary depending on the Member State and on the substance, lead to obstacles to trade in licit uses, fragmentation, an uneven level playing field and legal uncertainties for economic operators, and make it difficult for companies to operate across the internal market. They make research more cumbersome, hampering the development of new uses for these substances.

      In this context, the case for swifter, more effective and more proportionate action on new psychoactive substances at EU level is compelling, considering the rapid changes in this market, which put national authorities under pressure to act.

      The Commission Communication "Towards a stronger European response to drugs", adopted in October 2011, identified the spread of new psychoactive substances as one of the most challenging developments in drugs policy requiring a firmer EU response.

      IMPACT ASSESSMENT: taking into account the results of impact assessment, the following solutions are preferred: (i) a more graduated and better targeted set of restriction measures on new psychoactive substances, which should not hinder the industrial use of substances; (ii) restriction measures should be introduced earlier; (iii) substances suspected to pose immediate public health risks should be subjected to temporary restrictions; (iv) restriction measures should be proportionate to a better determined level of risk of substances; (v) restriction measures should be introduced through a quicker procedure.

      LEGAL BASIS: Article 114 of the Treaty on the Functioning of the European Union.

      CONTENT: this proposed Regulation – which is intended to replace Council Decision 2005/387/JHA - aims at ensuring that trade in new psychoactive substances having industrial and commercial uses is not hindered and that the functioning of this market is improved, while the health and safety of individuals are protected from harmful substances, which cause concern at the EU level.

      The proposal is accompanied by a proposal for a Directive amending Council Framework Decision 2004/757/JHA laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking.

      The main elements of the proposal are as follows:

      Exchange of information and temporary consumer market restrictions: this proposal sets up a robust system: (i) for exchanging rapidly information on new psychoactive substances emerging on the market, including on their commercial and industrial uses, for assessing the risks of substances that cause EU-wide concern and; (ii) for withdrawing from the market those substances that pose risks.

      The substances suspected to pose immediate public health risk will be withdrawn from the consumer market temporarily, pending their risk assessment. Once the risk assessment is completed, measures will be taken proportionate to the risks of substances.

      The proposal establishes the respective roles of Member States, the EMCDDA and Europol in the process of exchange of information on new psychoactive substances.

      Low and moderate risks: according to the proposal, no restriction measures shall be introduced on new psychoactive substances posing low health, social and safety risks and provides a definition of low risks.

      For substances posing moderate risks and permanent consumer market restrictions, they cannot be sold to consumers (except for uses specifically authorised, for instance by medicines legislation) but their trade is allowed for commercial and industrial purposes as well as for scientific research and development.

      Severe risks: the proposal empowers the Commission to prohibit the production, manufacture, making available on the market, transport, importation or exportation of new psychoactive substances which pose severe health, social and safety risks, and provides a definition of severe risks.

      New psychoactive substances posing severe risks will be subjected to permanent market restriction, covering both the consumer and commercial markets, and their use will only be possible for specifically authorised industrial and commercial purposes, as well as for scientific research and development. In addition, these substances will be subjected to EU criminal law provisions.

      Sanctions: the proposal establishes the obligation for the Member States to lay down the rules on administrative sanctions applicable to infringements to market restriction, and to ensure that they are effective, proportionate and dissuasive.

      BUDGETARY IMPLICATION: the proposal has no direct impact on the EU budget and does not create new tasks for the EMCDDA, Europol, the European Medicines Agencies, the European Chemicals Agency (ECHA) and the European Food Safety Authority (EFSA).

    celexid
    CELEX:52013PC0619:EN
    type
    Legislative proposal published
    title
    COM(2013)0619
type
Legislative proposal published
body
EC
commission
  • DG
    Commissioner
    REDING Viviane
activities/0/body
Old
EP
New
EC
activities/0/commission
  • DG
    Commissioner
    REDING Viviane
activities/0/date
Old
2014-04-17T00:00:00
New
2013-09-17T00:00:00
activities/0/docs
  • url
    http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2013&nu_doc=619
    text
    • PURPOSE: to approximate the rules relating to new psychoactive substances that are of concern at Union level whilst ensuring a high level of health, safety and consumer protection.

      PROPOSED ACT: Regulation of the European Parliament and of the Council.

      ROLE OF THE EUROPEAN PARLIAMENT: the European Parliament decides in accordance with the ordinary legislative procedure and on an equal footing with the Council.

      BACKGROUND: new psychoactive substances, which may have numerous commercial and industrial uses, as well as scientific uses, can pose health, social and safety risks when consumed by humans. Consumption of new psychoactive substances appears to be increasing in Europe and use is predominant among young people. According to the 2011 Eurobarometer "Youth attitudes on drugs", 5% of young people in the EU have used such substances at least once in their life, with a peak of 16% in Ireland, and close to 10% in Poland, Latvia and the UK.

      During the past years, Member States have notified an increasing number of new psychoactive substances to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). National restriction measures, which can vary depending on the Member State and on the substance, lead to obstacles to trade in licit uses, fragmentation, an uneven level playing field and legal uncertainties for economic operators, and make it difficult for companies to operate across the internal market. They make research more cumbersome, hampering the development of new uses for these substances.

      In this context, the case for swifter, more effective and more proportionate action on new psychoactive substances at EU level is compelling, considering the rapid changes in this market, which put national authorities under pressure to act.

      The Commission Communication "Towards a stronger European response to drugs", adopted in October 2011, identified the spread of new psychoactive substances as one of the most challenging developments in drugs policy requiring a firmer EU response.

      IMPACT ASSESSMENT: taking into account the results of impact assessment, the following solutions are preferred: (i) a more graduated and better targeted set of restriction measures on new psychoactive substances, which should not hinder the industrial use of substances; (ii) restriction measures should be introduced earlier; (iii) substances suspected to pose immediate public health risks should be subjected to temporary restrictions; (iv) restriction measures should be proportionate to a better determined level of risk of substances; (v) restriction measures should be introduced through a quicker procedure.

      LEGAL BASIS: Article 114 of the Treaty on the Functioning of the European Union.

      CONTENT: this proposed Regulation – which is intended to replace Council Decision 2005/387/JHA - aims at ensuring that trade in new psychoactive substances having industrial and commercial uses is not hindered and that the functioning of this market is improved, while the health and safety of individuals are protected from harmful substances, which cause concern at the EU level.

      The proposal is accompanied by a proposal for a Directive amending Council Framework Decision 2004/757/JHA laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking.

      The main elements of the proposal are as follows:

      Exchange of information and temporary consumer market restrictions: this proposal sets up a robust system: (i) for exchanging rapidly information on new psychoactive substances emerging on the market, including on their commercial and industrial uses, for assessing the risks of substances that cause EU-wide concern and; (ii) for withdrawing from the market those substances that pose risks.

      The substances suspected to pose immediate public health risk will be withdrawn from the consumer market temporarily, pending their risk assessment. Once the risk assessment is completed, measures will be taken proportionate to the risks of substances.

      The proposal establishes the respective roles of Member States, the EMCDDA and Europol in the process of exchange of information on new psychoactive substances.

      Low and moderate risks: according to the proposal, no restriction measures shall be introduced on new psychoactive substances posing low health, social and safety risks and provides a definition of low risks.

      For substances posing moderate risks and permanent consumer market restrictions, they cannot be sold to consumers (except for uses specifically authorised, for instance by medicines legislation) but their trade is allowed for commercial and industrial purposes as well as for scientific research and development.

      Severe risks: the proposal empowers the Commission to prohibit the production, manufacture, making available on the market, transport, importation or exportation of new psychoactive substances which pose severe health, social and safety risks, and provides a definition of severe risks.

      New psychoactive substances posing severe risks will be subjected to permanent market restriction, covering both the consumer and commercial markets, and their use will only be possible for specifically authorised industrial and commercial purposes, as well as for scientific research and development. In addition, these substances will be subjected to EU criminal law provisions.

      Sanctions: the proposal establishes the obligation for the Member States to lay down the rules on administrative sanctions applicable to infringements to market restriction, and to ensure that they are effective, proportionate and dissuasive.

      BUDGETARY IMPLICATION: the proposal has no direct impact on the EU budget and does not create new tasks for the EMCDDA, Europol, the European Medicines Agencies, the European Chemicals Agency (ECHA) and the European Food Safety Authority (EFSA).

    title
    COM(2013)0619
    type
    Legislative proposal published
    celexid
    CELEX:52013PC0619:EN
activities/0/type
Old
Vote in plenary scheduled
New
Legislative proposal published
activities/3/docs
  • url
    http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=3290*&MEET_DATE=28/01/2014
    type
    Debate in Council
    title
    3290
activities/3/docs
  • url
    http://register.consilium.europa.eu/content/out?lang=EN&ff_FT_TEXT=3290&dd_DATE_REUNION=28/01/2014&single_date=28/01/2014
    type
    Debate in Council
    title
    3290
activities/5/docs/0/text
  • The Committee on Civil Liberties, Justice and Home Affairs adopted the report by Jacek PROTASIEWICZ (EPP, PL) on the proposal for a regulation of the European Parliament and of the Council on new psychoactive substances.

    The committee recommended that Parliament’s position in first reading following the ordinary legislative procedure should amend the Commission position as follows:

    Information exchange: to enable a more effective response to the rapid emergence and spread of new psychoactive substances across the Union, Members considered that the information exchange mechanism (the 'Early Warning System') should be maintained and further developed, in particular as regards to the collection and management of data on the detection and identification of new psychoactive substances.

    The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) should issue health alerts to all Member States, through the system for rapid exchange of information on new psychoactive substances if, on the basis of information received on a new psychoactive substances, this seemed to cause public health concerns. Those health alerts should also contain information regarding prevention, treatment and harm reduction measures that could be taken to address the risk of the substance.

    Immediate risks to public health, and market restrictions: the proposal provided that the Commission should, by means of a Decision, prohibit the making available on the market to consumers of the new psychoactive substance if, based on existing information, it poses immediate risks to public health. The market restriction should not exceed a period of twelve months.

    Members proposed that if the level of health, social and safety risks posed by the new psychoactive substance justified the introduction of permanent restriction measures, the duration of the temporary market restriction may be extended by a further 12 months, in the absence of permanent market restriction.

    Low risks at Union level: the Commission should not adopt restriction measures on a new psychoactive substance if, based on the existing evidence and on prescribed criteria, it posed, overall, low health, social and safety risks at Union level.

    However, where the decision to not adopt restriction measures on a new psychoactive substance that was considered to pose overall low health, social and safety risk at Union level was based on a partial or total lack of evidence, it should include an appropriate reference in the justification.

    The report also stressed that Members States should not be prohibited from introducing or maintaining the more stringent measures regarding the specific risks the new psychoactive substance posed within their territory, independently of the classification of the substance by the Commission as posing low or moderate risks on the EU level. The relevant laws, regulations or administrative provisions should be communicated to the Commission and the other Member States should be informed.

    Authorised use: decisions prohibiting the marketing of new psychoactive substance presenting a serious risk should not impede the free movement in the Union and the production, manufacture, making available on the market of new psychoactive substances for scientific research and development purposes, by duly authorised persons in establishments which were directly under the control of Member States' authorities or specifically approved by them.

    For all of authorised uses, new psychoactive substances and products containing new psychoactive substances should include directions for use, including cautions, warnings and contraindications with other substances, to be either indicated on the label or included in the accompanying leaflet for the safety of the user.

    Furthermore, Member States should take any appropriate measures to prevent the diversion to the illicit market of new psychoactive substances used for research and development purposes or for any other authorised uses.

    Research, analysis, prevention and funding: the amended text provided that financial support and the necessary resources should be provided at Union and national level for the development, sharing and dissemination of information and knowledge on new psychoactive substances. 

    Moreover, the Commission and the Member States should promote the research into new psychoactive substances and ensure cooperation and coordination between networks at national and Union level in order to strengthen understanding of the phenomenon. 

    Prevention schemes as well as measures to raise awareness of the risks posed by psychoactive substances, such as educational information campaigns should be promoted.

    Evaluation: five years after the entry into force of the Regulation and every five years thereafter, the Commission should:

    • assess the implementation, application and effectiveness of this Regulation and publish a report. In this respect, the Commission, the EMCDDA and Europol should conduct post-risk assessments of new psychoactive substances;
    • evaluate and if appropriate present a proposal for possible classification of groups of the new psychoactive substances in order to counteract the practise of bypassing the legislation in force by slight modifications of the chemical structure of the psychoactive substances.
activities/0/docs/0/url
Old
http://old.eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2013&nu_doc=619
New
http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2013&nu_doc=619
activities/5/docs
  • url
    http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A7-2014-0172&language=EN
    type
    Committee report tabled for plenary, 1st reading/single reading
    title
    A7-0172/2014
activities/6/date
Old
2014-04-15T00:00:00
New
2014-04-17T00:00:00
activities/6/type
Old
Indicative plenary sitting date, 1st reading/single reading
New
Vote in plenary scheduled
activities/0/docs/0/url
Old
http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2013&nu_doc=619
New
http://old.eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2013&nu_doc=619
activities/3/docs/0/url
Old
http://www.europarl.europa.eu/ http://register.consilium.europa.eu/servlet/driver?page=Result&typ=Simple&cmsid=638&ff_COTE_DOCUMENT=&ff_TITRE=&ff_SOUS_COTE_MATIERE=&fc=REGAISEN&srm=25&md=400&ssf=DATE_DOCUMENT+DESC&single_comparator=%3D&from_date=&to_date=&lang=EN&ff_FT_TEXT=3290&dd_DATE_REUNION=28/01/2014&single_date=28/01/2014
New
http://register.consilium.europa.eu/content/out?lang=EN&ff_FT_TEXT=3290&dd_DATE_REUNION=28/01/2014&single_date=28/01/2014
activities/4
date
2014-03-10T00:00:00
body
EP
type
Vote in committee, 1st reading/single reading
committees
activities/5
date
2014-03-13T00:00:00
body
EP
type
Committee report tabled for plenary, 1st reading/single reading
committees
procedure/stage_reached
Old
Awaiting committee decision
New
Awaiting Parliament 1st reading / single reading / budget 1st stage
activities/4/date
Old
2014-04-03T00:00:00
New
2014-04-15T00:00:00
activities/4/date
Old
2014-04-17T00:00:00
New
2014-04-03T00:00:00
activities/4/date
Old
2014-04-15T00:00:00
New
2014-04-17T00:00:00
activities/3
body
CSL
meeting_id
3290
docs
  • url
    http://www.europarl.europa.eu/ http://register.consilium.europa.eu/servlet/driver?page=Result&typ=Simple&cmsid=638&ff_COTE_DOCUMENT=&ff_TITRE=&ff_SOUS_COTE_MATIERE=&fc=REGAISEN&srm=25&md=400&ssf=DATE_DOCUMENT+DESC&single_comparator=%3D&from_date=&to_date=&lang=EN&ff_FT_TEXT=3290&dd_DATE_REUNION=28/01/2014&single_date=28/01/2014
    type
    Debate in Council
    title
    3290
council
Economic and Financial Affairs ECOFIN
date
2014-01-28T00:00:00
type
Council Meeting
other/0
body
CSL
type
Council Meeting
council
Former Council configuration
activities/0/docs/1
url
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=SWD:2013:0319:FIN:EN:PDF
type
Document attached to the procedure
title
SWD(2013)0319
activities/0/docs/2
url
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=SWD:2013:0320:FIN:EN:PDF
type
Document attached to the procedure
title
SWD(2013)0320
activities/0/type
Old
Legislative proposal
New
Legislative proposal published
activities/3
date
2013-12-23T00:00:00
docs
  • url
    http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE519.611
    type
    Committee draft report
    title
    PE519.611
body
EP
type
Committee draft report
activities/4/date
Old
2014-03-11T00:00:00
New
2014-04-15T00:00:00
activities/3/docs/0/url
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE519.611
activities/3
date
2013-12-23T00:00:00
docs
  • type
    Committee draft report
    title
    PE519.611
body
EP
type
Committee draft report
activities/0/docs/0/celexid
CELEX:52013PC0619:EN
activities/0/docs/0/celexid
CELEX:52013PC0619:EN
activities/3
date
2014-03-11T00:00:00
body
EP
type
Indicative plenary sitting date, 1st reading/single reading
activities/2/committees/1/shadows/2
group
Verts/ALE
name
SCHLYTER Carl
committees/1/shadows/2
group
Verts/ALE
name
SCHLYTER Carl
activities/2/committees/1/shadows/1
group
ALDE
name
WEBER Renate
committees/1/shadows/1
group
ALDE
name
WEBER Renate
procedure/summary
  • See also
activities/2/committees/1/shadows/0
group
S&D
name
HEDH Anna
committees/1/shadows/0
group
S&D
name
HEDH Anna
links/National parliaments
url
http://www.ipex.eu/IPEXL-WEB/dossier/dossier.do?code=COD&year=2013&number=0305&appLng=EN
title
IPEX
activities/2/committees/1/shadows
  • group
    ECR
    name
    KIRKHOPE Timothy
  • group
    GUE/NGL
    name
    TRIANTAPHYLLIDES Kyriacos
committees/1/shadows
  • group
    ECR
    name
    KIRKHOPE Timothy
  • group
    GUE/NGL
    name
    TRIANTAPHYLLIDES Kyriacos
procedure/summary
  • See also
procedure/summary
  • See also
activities/0/docs/0/text
  • PURPOSE: to approximate the rules relating to new psychoactive substances that are of concern at Union level whilst ensuring a high level of health, safety and consumer protection.

    PROPOSED ACT: Regulation of the European Parliament and of the Council.

    ROLE OF THE EUROPEAN PARLIAMENT: the European Parliament decides in accordance with the ordinary legislative procedure and on an equal footing with the Council.

    BACKGROUND: new psychoactive substances, which may have numerous commercial and industrial uses, as well as scientific uses, can pose health, social and safety risks when consumed by humans. Consumption of new psychoactive substances appears to be increasing in Europe and use is predominant among young people. According to the 2011 Eurobarometer "Youth attitudes on drugs", 5% of young people in the EU have used such substances at least once in their life, with a peak of 16% in Ireland, and close to 10% in Poland, Latvia and the UK.

    During the past years, Member States have notified an increasing number of new psychoactive substances to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). National restriction measures, which can vary depending on the Member State and on the substance, lead to obstacles to trade in licit uses, fragmentation, an uneven level playing field and legal uncertainties for economic operators, and make it difficult for companies to operate across the internal market. They make research more cumbersome, hampering the development of new uses for these substances.

    In this context, the case for swifter, more effective and more proportionate action on new psychoactive substances at EU level is compelling, considering the rapid changes in this market, which put national authorities under pressure to act.

    The Commission Communication "Towards a stronger European response to drugs", adopted in October 2011, identified the spread of new psychoactive substances as one of the most challenging developments in drugs policy requiring a firmer EU response.

    IMPACT ASSESSMENT: taking into account the results of impact assessment, the following solutions are preferred: (i) a more graduated and better targeted set of restriction measures on new psychoactive substances, which should not hinder the industrial use of substances; (ii) restriction measures should be introduced earlier; (iii) substances suspected to pose immediate public health risks should be subjected to temporary restrictions; (iv) restriction measures should be proportionate to a better determined level of risk of substances; (v) restriction measures should be introduced through a quicker procedure.

    LEGAL BASIS: Article 114 of the Treaty on the Functioning of the European Union.

    CONTENT: this proposed Regulation – which is intended to replace Council Decision 2005/387/JHA - aims at ensuring that trade in new psychoactive substances having industrial and commercial uses is not hindered and that the functioning of this market is improved, while the health and safety of individuals are protected from harmful substances, which cause concern at the EU level.

    The proposal is accompanied by a proposal for a Directive amending Council Framework Decision 2004/757/JHA laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking.

    The main elements of the proposal are as follows:

    Exchange of information and temporary consumer market restrictions: this proposal sets up a robust system: (i) for exchanging rapidly information on new psychoactive substances emerging on the market, including on their commercial and industrial uses, for assessing the risks of substances that cause EU-wide concern and; (ii) for withdrawing from the market those substances that pose risks.

    The substances suspected to pose immediate public health risk will be withdrawn from the consumer market temporarily, pending their risk assessment. Once the risk assessment is completed, measures will be taken proportionate to the risks of substances.

    The proposal establishes the respective roles of Member States, the EMCDDA and Europol in the process of exchange of information on new psychoactive substances.

    Low and moderate risks: according to the proposal, no restriction measures shall be introduced on new psychoactive substances posing low health, social and safety risks and provides a definition of low risks.

    For substances posing moderate risks and permanent consumer market restrictions, they cannot be sold to consumers (except for uses specifically authorised, for instance by medicines legislation) but their trade is allowed for commercial and industrial purposes as well as for scientific research and development.

    Severe risks: the proposal empowers the Commission to prohibit the production, manufacture, making available on the market, transport, importation or exportation of new psychoactive substances which pose severe health, social and safety risks, and provides a definition of severe risks.

    New psychoactive substances posing severe risks will be subjected to permanent market restriction, covering both the consumer and commercial markets, and their use will only be possible for specifically authorised industrial and commercial purposes, as well as for scientific research and development. In addition, these substances will be subjected to EU criminal law provisions.

    Sanctions: the proposal establishes the obligation for the Member States to lay down the rules on administrative sanctions applicable to infringements to market restriction, and to ensure that they are effective, proportionate and dissuasive.

    BUDGETARY IMPLICATION: the proposal has no direct impact on the EU budget and does not create new tasks for the EMCDDA, Europol, the European Medicines Agencies, the European Chemicals Agency (ECHA) and the European Food Safety Authority (EFSA).

activities/2/committees/0/date
2013-10-10T00:00:00
activities/2/committees/0/rapporteur
  • group
    EPP
    name
    ANTONESCU Elena Oana
committees/0/date
2013-10-10T00:00:00
committees/0/rapporteur
  • group
    EPP
    name
    ANTONESCU Elena Oana
activities/2
date
2013-10-08T00:00:00
body
EP
type
Committee referral announced in Parliament, 1st reading/single reading
committees
procedure/dossier_of_the_committee
LIBE/7/13824
procedure/stage_reached
Old
Preparatory phase in Parliament
New
Awaiting committee decision
activities/1
date
2013-10-07T00:00:00
body
CSL
type
Council Meeting
council
Justice and Home Affairs (JHA)
meeting_id
3260
procedure/Mandatory consultation of other institutions
Economic and Social Committee
activities
  • date
    2013-09-17T00:00:00
    docs
    body
    EC
    type
    Legislative proposal
    commission
    • DG
      Commissioner
      REDING Viviane
committees
  • body
    EP
    responsible
    False
    committee_full
    Environment, Public Health and Food Safety
    committee
    ENVI
  • body
    EP
    responsible
    True
    committee
    LIBE
    date
    2013-09-30T00:00:00
    committee_full
    Civil Liberties, Justice and Home Affairs
    rapporteur
    • group
      EPP
      name
      PROTASIEWICZ Jacek
links
European Commission
other
  • body
    EC
    dg
    commissioner
    REDING Viviane
procedure
reference
2013/0305(COD)
title
New psychoactive substances
legal_basis
  • Treaty on the Functioning of the EU TFEU 114
stage_reached
Preparatory phase in Parliament
subtype
Legislation
instrument
Regulation
type
COD - Ordinary legislative procedure (ex-codecision procedure)
subject